4D Molecular Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 161.9% | 161.9% | 112.1% | 112.1% | 384.6% | 384.6% | 1,735.9% | 608.8% | 372.2% | 432.7% | 155.7% | – | 638.5% | 104.4% | 1,159.6% | 19,052.2% | 1,589.9% | 12,606.2% | 3,788.0% | 1,724.1% | 7,520.8% | 9,867.8% | 124.1% | – | 99,535.7% | 637,200.0% | 1,282,800.0% | 178,400.0% | 290,707.1% | 319,673.3% | 52,486.7% | 2.3% | 67.4% | 55.2% | 58.0% | |
| -61.9% | -61.9% | -12.1% | -12.1% | -284.6% | -284.6% | -1,635.9% | -508.8% | -272.2% | -332.7% | -55.7% | – | -538.5% | -4.4% | -1,059.6% | -18,952.2% | -1,489.9% | -12,506.2% | -3,688.0% | -1,624.1% | -7,420.8% | -9,767.8% | -24.1% | – | -99,435.7% | -637,100.0% | -1,282,700.0% | -178,300.0% | -290,607.1% | -319,573.3% | -52,386.7% | 97.7% | 32.6% | 44.8% | 42.0% | |
| 161.9% | 161.9% | 112.1% | 112.1% | 384.6% | 384.6% | 1,735.9% | 608.8% | 372.2% | 432.7% | 155.7% | – | 638.5% | 104.4% | 1,159.6% | 19,052.2% | 1,589.9% | 12,606.2% | 3,788.0% | 1,724.1% | 7,520.8% | 9,867.8% | 124.1% | – | 99,535.7% | 637,200.0% | 1,282,800.0% | 4,308,500.0% | 290,707.1% | 319,673.3% | 54,931.1% | 67.7% | 2,132.6% | 1,805.9% | 261.2% | |
| 43.4% | 43.4% | 43.8% | 43.8% | 110.6% | 110.6% | 565.2% | 293.5% | 103.4% | 84.3% | 49.6% | – | 277.2% | 47.7% | 599.3% | 7,965.2% | 675.1% | 5,040.7% | 1,611.0% | 679.0% | 2,681.9% | 3,678.2% | 45.1% | – | 36,764.3% | 212,020.0% | 421,700.0% | 1,303,300.0% | 92,400.0% | 76,800.0% | 13,152.2% | 15.0% | 383.6% | 331.2% | 53.1% | |
| 43.3% | 43.3% | 43.9% | 43.9% | 110.8% | 110.8% | 2,301.1% | 902.4% | 103.4% | 84.3% | 49.6% | – | 277.2% | 47.7% | 599.3% | 7,965.2% | 675.1% | 5,040.7% | 1,611.0% | 679.0% | 2,681.9% | 3,678.2% | 45.1% | – | 36,764.3% | 212,020.0% | 421,700.0% | 5,433,400.0% | 92,400.0% | 76,800.0% | 15,596.7% | 80.4% | 2,448.7% | 2,081.9% | 256.2% | |
| -105.3% | -105.3% | -55.9% | -55.9% | -395.2% | -395.2% | -3,152.4% | -802.4% | -375.6% | -417.0% | -105.3% | – | -815.6% | -52.1% | -1,658.9% | -26,917.4% | -2,165.1% | -17,546.9% | -5,299.0% | -2,303.1% | -10,102.7% | -13,446.0% | -69.2% | – | -136,200.0% | -849,120.0% | -1,704,400.0% | -5,611,700.0% | -383,007.1% | -396,373.3% | -67,983.3% | 17.3% | -2,416.1% | -2,037.2% | -214.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 339.1% | 8.2% | 209.9% | 159.0% | 99.0% | 473.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -102.3% | -102.3% | -48.2% | -48.2% | -374.0% | -374.0% | -3,088.0% | -793.8% | -372.3% | -417.1% | -105.6% | – | -820.3% | -52.1% | -1,628.0% | -27,264.1% | -2,160.6% | -17,337.0% | -5,138.2% | -2,195.6% | -9,624.8% | -12,391.6% | -50.8% | – | -115,717.9% | -699,060.0% | -1,461,433.3% | -4,967,100.0% | -342,657.1% | -364,386.7% | -63,195.6% | 22.8% | -2,256.6% | -1,929.0% | -194.7% | |
| – | – | – | – | – | – | -63.1% | -10.7% | -3.7% | -0.4% | -0.1% | – | -0.4% | – | -31.8% | 339.1% | -12.6% | -419.8% | -319.8% | -8.5% | -477.9% | -597.5% | -19.2% | – | 0.0% | – | – | 0.1% | – | – | – | – | – | – | – | |
| -102.3% | -102.3% | -48.2% | -48.2% | -374.0% | -374.0% | -3,088.0% | -793.8% | -372.3% | -417.1% | -105.6% | – | -820.3% | -52.1% | -1,628.0% | -27,264.1% | -2,160.6% | -17,337.0% | -5,138.2% | -2,195.6% | -9,624.8% | -12,391.6% | -50.8% | – | -115,717.9% | -699,060.0% | -1,461,433.3% | -4,967,100.0% | -342,657.1% | -364,386.7% | -63,195.6% | 22.8% | -2,256.6% | -1,929.0% | -194.7% | |
| -98.6% | -98.6% | -51.9% | -51.9% | -386.0% | -386.0% | -2,149.3% | -786.7% | -365.9% | -407.1% | -100.4% | – | -796.5% | -49.5% | -1,600.2% | -26,501.1% | -2,127.3% | -17,049.4% | -5,034.8% | -2,114.3% | -9,279.5% | -11,940.2% | -45.8% | – | -111,528.6% | -675,180.0% | -1,404,666.7% | -4,788,700.0% | -330,128.6% | -356,613.3% | -61,794.4% | 14.6% | -2,189.2% | -1,981.9% | -200.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.